查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1825316

栓塞保護裝置市場：2025-2030 年預測

Embolic Protection Devices Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 147 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

栓塞防護裝置市場預計將從 2025 年的 711,396,000 美元成長到 2030 年的 1,045,758,000 美元，複合年成長率為 8.01%。

栓塞保護裝置 (EPD) 市場是介入性心臟病學和血管外科領域的一個細分市場，致力於預防高風險手術中的併發症。這些裝置旨在收集隱靜脈移植物 (SVG) 和其他血管結構內的血液和管腔碎片，最大限度地減少遠端栓塞，並降低圍手術期心肌梗塞和主要不良心血管事件 (MACE) 的風險。

技術平台及臨床應用

栓塞防護裝置的作用是在經皮心臟和血管介入治療過程中捕獲並清除脫落的物質，防止碎片堵塞下游小動脈。該技術提供實證保護，防止斑塊顆粒遷移到遠端血管床，從而提高手術安全性和患者預後。

其主要臨床應用包括頸動脈置入術和隱靜脈移植介入治療，這兩種介入治療均具有極高的栓塞風險。該裝置也正在評估其在腎動脈和其他血管區域的應用，但在這些應用中的臨床有效性仍需進一步的對照試驗檢驗。

其根本價值提案是透過機械阻斷可能導致下游血管併發症的碎片來預防不良臨床後果。這種保護機制已在成熟的應用中顯示出顯著的臨床益處，尤其是在高風險患者群體中。

市場成長的關鍵驅動力

心血管和神經血管疾病盛行率的上升是市場的主要驅動力，從而對介入手術中的防護技術產生了持續的需求。心血管疾病負擔的不斷加重，使得受益於栓塞保護的手術和非手術治療方法的應用日益增加。

經導管主動脈瓣置換術(TAVR) 的推廣正在創造更大的市場需求，因為這種複雜的介入手術本身就具有栓塞風險，而這些風險可以透過保護裝置來降低。隨著 TAVR 系統被更廣泛的患者群體所採用，對全面栓塞防護策略的需求也日益成長。

提高消費者和醫生對栓塞防護設備的認知，將有助於改善手術規劃和風險緩解策略，進而促進市場成長。教育活動和臨床證據的傳播將增進人們對該設備優勢和合適使用情境的理解。

微創手術的需求將推動市場擴張，因為這些手術通常涉及較高的栓塞風險，需要採取保護措施。器械設計、輸送能力和療效的技術改進將進一步推動市場成長，擴大其適用範圍並改善手術效果。

政府機構、非政府組織和教育機構正在進行有關心血管和神經血管疾病及其治療方案的宣傳活動，從而透過增加治療量和風險意識間接支持市場成長。

地理市場分佈

北美是心血管疾病高發生率地區，且醫療基礎設施先進，支援複雜的介入手術，因此是主要的細分市場。肥胖、生活方式和飲食習慣等區域性因素加劇了心血管疾病的負擔，從而對防護技術產生了持續的需求。

北美擁有眾多產業參與企業，透過技術創新、臨床研究和產品供應支持市場發展。該地區的法規環境和報銷框架促進了醫療器材的普及和市場滲透。

亞太地區擁有巨大的成長潛力，主要原因是人口老化加劇，更容易罹患心血管和神經病變。都市化趨勢、生活方式的改變以及肥胖和高血壓等風險因素的日益普遍，為市場擴張提供了機會。

中國等國家的政府支持和醫療改革透過改善先進醫療技術和介入程序的獲取，為市場發展創造了有利條件。

市場限制與技術挑戰

高產品故障率是市場成長的一大限制因素，為廣泛應用帶來了臨床和經濟方面的障礙。在關鍵手術過程中，設備故障會危及病人安全，並降低醫生對技術的信心。

產品召回和品質問題導致設備可靠性和性能存在不確定性，進一步阻礙了市場擴張。醫療設備業高度重視安全性和有效性，要求產品性能始終如一，以維持市場認可。

栓塞保護裝置的報銷政策不足，為醫療服務提供者和患者帶來了經濟障礙，限制了其應用。限制性的保險覆蓋政策可能會將其使用限制在某些高風險情況下，從而限制整體市場的成長潛力。

競爭格局

該市場由知名醫療設備公司組成，包括雅培實驗室、波士頓科學公司、美敦力公司、戈爾醫療、康德樂健康、創新心血管解決方案、Emboline 公司、NIPRO、絲綢之路醫療和 Keystone Heart（啟明醫療），他們透過產品創新、臨床證據生成和戰略市場定位展開競爭。

戰略產業影響

對於醫療設備業的專業人士來說，栓塞保護器材市場代表著介入性心臟病學進展與病人安全提升交會的機會。成功的關鍵在於平衡技術創新與臨床證據發展，並兼顧成本效益考量，因為這些因素會影響不同醫療體系的採用決策。

本報告的主要優點

  • 深刻分析：獲得涵蓋主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
  • 競爭格局：了解主要企業所採用的策略策略，並了解正確策略的市場滲透潛力。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力進行策略決策，並在動態環境中開闢新的業務流和收益。
  • 適合廣泛的使用者：對於新興企業、研究機構、顧問、中小企業和大型企業來說都是有益且具有成本效益的。

它有什麼用途？

產業和市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響

調查範圍

  • 2022 年至 2024 年的歷史數據和 2025 年至 2030 年的預測數據
  • 成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 收益成長和預測細分市場和區域分析（包括國家）
  • 公司概況（尤其是財務狀況和關鍵發展）

目錄

第1章執行摘要

第2章市場概述

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 經營狀況

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策法規
  • 策略建議

第4章 技術展望

5. 栓塞保護裝置市場（按類型）

  • 介紹
  • 遠端閉塞系統
  • 近端閉塞系統
  • 遠端過濾系統

6. 栓塞保護裝置市場（依程序）

  • 介紹
  • 冠狀動脈手術
  • 周邊動脈手術
  • 頸動脈手術
  • 腎動脈手術
  • 其他

7. 栓塞保護裝置市場（依最終用戶）

  • 介紹
  • 醫院
  • 門診手術中心
  • 專科診所

8. 栓塞保護裝置市場（按地區）

  • 介紹
  • 北美洲
    • 按類型
    • 透過手術
    • 按最終用戶
    • 按國家
      • 美國
      • 加拿大
      • 墨西哥
  • 南美洲
    • 按類型
    • 透過手術
    • 按最終用戶
    • 按國家
      • 巴西
      • 阿根廷
      • 其他
  • 歐洲
    • 按類型
    • 透過手術
    • 按最終用戶
    • 按國家
      • 英國
      • 德國
      • 法國
      • 西班牙
      • 其他
  • 中東和非洲
    • 按類型
    • 透過手術
    • 按最終用戶
    • 按國家
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 其他
  • 亞太地區
    • 按類型
    • 透過手術
    • 按最終用戶
    • 按國家
      • 中國
      • 日本
      • 印度
      • 韓國
      • 台灣
      • 其他

第9章：競爭格局及分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第10章：公司簡介

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic Plc.
  • Silk Road Medical, Inc.
  • Emboline Inc.
  • Nipro Corporation
  • Edwards Lifesciences

第11章 附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061610441

The Embolic Protection Devices Market is expected to grow from USD 711.396 million in 2025 to USD 1,045.758 million in 2030, at a CAGR of 8.01%.

The embolic protection devices (EPDs) market represents a specialized segment within interventional cardiology and vascular surgery, focused on preventing periprocedural complications during high-risk procedures. These devices are designed to collect blood and luminal debris within saphenous vein grafts (SVG) and other vascular structures, minimizing distant embolization and reducing the risk of periprocedural myocardial infarction and major adverse cardiovascular events (MACE).

Technology Foundation and Clinical Applications

Embolic protection devices function by capturing and removing dislodged material during percutaneous cardiac and vascular interventions, preventing debris from causing blockages in smaller downstream arteries. The technology provides evidence-based protection against plaque particle migration to distal vascular beds, improving procedural safety and patient outcomes.

Primary clinical applications include carotid artery stenting procedures and saphenous vein graft interventions, where the risk of embolic events is particularly elevated. The devices are also being evaluated for use in renal arteries and other vascular territories, though clinical effectiveness in these applications requires further validation through controlled studies.

The fundamental value proposition centers on preventing unfavorable clinical outcomes by mechanically intercepting debris that would otherwise cause downstream vascular complications. This protective mechanism has demonstrated significant clinical benefit in established applications, particularly in high-risk patient populations.

Primary Market Growth Drivers

The rising prevalence of cardiovascular and neurovascular disorders represents the most significant market driver, creating sustained demand for protective technologies during interventional procedures. The growing burden of cardiovascular disease necessitates increased utilization of surgical and non-surgical treatment modalities that benefit from embolic protection.

The expansion of Trans-catheter Aortic Valve Replacement (TAVR) procedures creates additional market demand, as these complex interventions carry inherent embolic risks that protection devices can mitigate. The growing adoption of TAVR systems across broader patient populations amplifies the need for comprehensive embolic protection strategies.

Increasing consumer and physician awareness of embolic protection devices contributes to market growth through improved procedural planning and risk mitigation strategies. Educational initiatives and clinical evidence dissemination enhance understanding of device benefits and appropriate utilization scenarios.

The demand for less invasive procedures drives market expansion, as minimally invasive interventions often carry higher embolic risks that require protective measures. Technical improvements in device design, deliverability, and effectiveness further support market growth by expanding the range of suitable applications and improving procedural outcomes.

Government agencies, non-governmental organizations, and educational institutions are conducting awareness campaigns regarding cardiovascular and neurovascular diseases and their treatment options, indirectly supporting market growth through increased procedural volumes and risk awareness.

Geographic Market Distribution

North America represents a leading market segment, driven by high cardiovascular disease prevalence and advanced healthcare infrastructure supporting complex interventional procedures. Regional factors including obesity, lifestyle patterns, and dietary habits contribute to cardiovascular disease burden, creating sustained demand for protective technologies.

The strong presence of key industry participants in North America supports market development through innovation, clinical research, and product availability. The region's regulatory environment and reimbursement frameworks facilitate device adoption and market penetration.

The Asia Pacific region presents significant growth potential, supported by rapidly aging populations susceptible to cardiovascular and neurological disorders. Urbanization trends, lifestyle changes, and increasing prevalence of risk factors including obesity and hypertension contribute to market expansion opportunities.

Government support and healthcare reforms in countries such as China create favorable conditions for market development through improved access to advanced medical technologies and interventional procedures.

Market Constraints and Technical Challenges

High product failure rates represent a significant constraint on market growth, creating clinical and economic barriers to widespread adoption. Device failures during critical procedures can compromise patient safety and reduce physician confidence in the technology.

Product recalls and quality issues further impede market expansion by creating uncertainty regarding device reliability and performance. The medical device industry's emphasis on safety and efficacy requires consistent product performance to maintain market acceptance.

Inadequate reimbursement policies for embolic protection devices limit adoption by creating economic barriers for healthcare providers and patients. Limited coverage policies may restrict utilization to specific high-risk scenarios, constraining overall market growth potential.

Competitive Landscape

The market features established medical device companies including Abbott Laboratories, Boston Scientific Inc., Medtronic Plc., Gore Medical, Cardinal Health, Innovative Cardiovascular Solutions, Emboline Inc., NIPRO, Silk Road Medical, and Keystone Heart (Venus MedTech). These companies compete through product innovation, clinical evidence generation, and strategic market positioning.

Strategic Industry Implications

For medical device industry professionals, the embolic protection devices market represents opportunities at the intersection of interventional cardiology advancement and patient safety improvement. Success requires balancing technological innovation with clinical evidence development and addressing cost-effectiveness considerations that influence adoption decisions across diverse healthcare systems.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Embolic Protection Devices Market Segmentation:

By Type

  • Distal Occlusion Systems
  • Proximal Occlusion Systems
  • Distal Filter Systems

By Procedure

  • Coronary Artery Procedures
  • Peripheral Artery Procedures
  • Carotid Artery Procedures
  • Renal Artery Procedures
  • Others

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. EMBOLIC PROTECTION DEVICES MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Distal Occlusion Systems
  • 5.3. Proximal Occlusion Systems
  • 5.4. Distal Filter Systems

6. EMBOLIC PROTECTION DEVICES MARKET BY PROCEDURE

  • 6.1. Introduction
  • 6.2. Coronary Artery Procedures
  • 6.3. Peripheral Artery Procedures
  • 6.4. Carotid Artery Procedures
  • 6.5. Renal Artery Procedures
  • 6.6. Others

7. EMBOLIC PROTECTION DEVICES MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Specialty Clinics

8. EMBOLIC PROTECTION DEVICES MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Procedure
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Procedure
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Procedure
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Procedure
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Procedure
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Abbott Laboratories
  • 10.2. Boston Scientific Corporation
  • 10.3. Medtronic Plc.
  • 10.4. Silk Road Medical, Inc.
  • 10.5. Emboline Inc.
  • 10.6. Nipro Corporation
  • 10.7. Edwards Lifesciences

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations